Endocrine oncology

Thyroglobulin Cutoffs after Total Thyroidectomy Without Radioiodine in Low- to Intermediate-Risk Thyroid Cancer: A Multicenter Cohort Study

ThyroidPublished Retrospective cohort study

Authors' conclusion

Unstimulated Tg levels are strongly associated with the risk of structural recurrence in patients with DTC who have undergone total thyroidectomy without RAI. The current cutoff values of 0.2 ng/mL and 5.0 ng/mL were clinically relevant, and Tg kinetics over time further improved risk stratification. These findings provide the first large-scale evidence from an East Asian cohort and underscore the importance of early, serial Tg assessment in this growing patient population.

Study context

Population
Patients with low- to intermediate-risk differentiated thyroid cancer (DTC) after total thyroidectomy without radioactive iodine (RAI), 11 Korean tertiary hospitals
Participants
9,753 patients
Outcome
Structural recurrence; optimal unstimulated Tg cutoffs (ROC and survival analyses)
Follow-up
Tg at 6, 12 and 24 months postoperatively
Methodological detailsmulticentre, 11 Korean tertiary hospitals
  • Multicentre
  • 11 Korean tertiary hospitals

Main finding

As reported in the abstract

Optimal unstimulated Tg cutoff for structural recurrence · 6, 12 and 24 months

Optimal thyroglobulin (Tg) cutoff

0.3 ng/mL

AUC at 6 months

0.815

AUC at 12 months

0.772

AUC at 24 months

0.816

Observational data: associations, not effects.

Further findings

Korean Thyroid Association (KTA) cutoffs

Tg ≥0.2 ng/mL (KTA excellent-response cutoff) showed high sensitivity for recurrence
Tg ≥5.0 ng/mL at 6 months (KTA biochemical incomplete response) independently predicted elevated recurrence risk

Recurrence-free survival by Tg level and Tg kinetics

Stepwise declines in recurrence-free survival with increasing Tg levels
Even Tg <0.2 or <0.3 ng/mL associated with recurrence if levels rose over time

Original publication

Thyroglobulin Cutoffs after Total Thyroidectomy Without Radioiodine in Low- to Intermediate-Risk Thyroid Cancer: A Multicenter Cohort Study. Thyroid. Published 23 December 2025. doi:10.1177/10507256251409134

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.